Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis

Cell Death and Differentiation

Volumn 14, Issue 8, 2007, Pages 1486-1496

  Kummer, J A ^a,b,c   Micheau, O ^a,d   Schneider, P ^a   Bovenschen, N ^c   Broekhuizen, R ^c   Quadir, R ^c   Strik, M C M ^e   Hack, C E ^e   Tschopp, J ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITÉ DE BOURGOGNE   (France)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CASPASE 10; CASPASE 8; CYSTEINE PROTEINASE; DEATH RECEPTOR; FAS LIGAND; GLUTAMIC ACID; PROCASPASE 10; PROCASPASE 8; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR 9; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SEQUENCE ANALYSIS;

ANIMALS; APOPTOSIS; CASPASE 10; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; FAS LIGAND PROTEIN; HUMANS; LIGANDS; MICE; MODELS, BIOLOGICAL; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, DEATH DOMAIN; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS; SERPINS; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447635084     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402152     Document Type: Article

References (38)

1. Shi Y. Mechanisms of caspace activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-470.
2. Lieberman J. The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal. Nat Rev Immunol 2003; 3: 361-370.
3. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994; 370: 650-652..
4. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Intergrating mammalian biology. Cell 2001; 104 487-501.
5. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505-512.
6. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997; 7: 831-836.
7. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-195.
8. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, Salvesen GS. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J Biol Chem 1997; 272: 7797-7800.
9. Tewari M, Dixit VM. Fas- and tumor necrosis factor-inducad apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 1995; 270: 3255-3260.
10. Bird PI. Serpins and regulation of cell death. Results Probl Cell Differ 1998; 24: 63-89.
11. Sprecher CA, Morgenstem KA, Mathewes S, Dahlen JR, Schrader SK, Foster DC et al. Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors. J Biol Chem 1995; 270: 29854-29861.
12. Bird CH, Sutton VR, Sun J, Hirst CE, Novak A, Kumar S et al. Selective regulation of apoptosis: The cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol 1998; 18: 6387-6398.
13. Zhang M, Park SM, Wang Y, Shah R, Liu N, Murmann AE et al. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. Immunity 2006; 24: 451-461.
14. Annand RR, Dahlen JR, Sprecher CA, De Dreu P, Foster DC, Mankovich JA et al. Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem J 1999; 342: 655-665.
15. Young JL, Sukhova GK, Foster D, Kisiel W, Libby P, Schonbeck U. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med 2000; 191: 1535-1544.
16. Bots M, VAN Bostelen L, Rademaker MT, Offringa R, Medema JP. Serpins prevent granzyme-induced death in a species-specific manner. Immunol Cell Biol 2006; 84: 79-86.
17. Micheau O, Tschopp J. Induction of TNF receptor 1-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-190.
18. Gettins PG. Serpin structure, mechanism, and function. Chem Rev 2002; 102: 4751-4804.
19. Bladergroen BA, Strik MC, Wolbink AM, Wouters D, Broekhuizen R, Kummer JA et al. The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells. Eur J Immunol 2005; 35: 1175-1183.
20. Bladergroen BA, Strik MC, Bovenschen N, van Berkum O, Scheffer GL, Meijer CJ et al. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J Immunol 2001; 166: 3218-3225.
21. Deng Y, Ren X, Yang L, Lin Y, Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003; 115: 61-70.
22. Benoit V, Chariot A, Delacroix L, Deregowski V, Jacobs N, Merville MP et al. Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expression. Cancer Res 2004; 64: 2684-2691.
23. Dickinson JL, Bates EJ, Ferrante A, Antalis TM. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem 1995; 270: 27894-27904.
24. Schleef RR, Chuang TL. Protease inhibitor 10 inhibits tumor necrosis factor alpha-induced cell death. Evidence for the formation of intracellular high M(r) protease inhibitor 10-containing complexes. J Biol Chem 2000; 275: 26385-26389.
25. Suminami Y, Nagashima S, Vujanovic NL, Hirabayashi K, Kato H, Whiteside TL. Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer 2000; 82 981-989.
26. Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW et al. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 2002; 277: 45162-45171.
27. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 2001; 276: 20633-20640.
28. Huntington JA, Read RJ, Carrell RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000; 407: 923-926.
29. Ziccardi RJ, Cooper NR. Active disassembly of the first complement component, C-1, by C-1 inactivator. J Immunol 1979; 123: 788-792.
30. Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J 2002; 21: 4520-4530.
31. Bladergroen BA, Meijer CJ, ten Berge RL, Hack CE, Muris JJ, Dukers DF et al. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor calls in patients with non-Hodgkin and Hodgkin lymphoma: A novel protective mechanism for tumor cells to circumvent the immune system? Blood 2002; 99: 232-237.
32. Oudejans JJ, Harijadi H, Kummer JA, Tan IB, Bioemena E, Middeldorp JM et al. High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcom in patients treated with curative intent. J Pathol 2002; 198: 468-475.
33. Medema JP, de Jong J, Peltenburg LT, Verdegaal EM, Gorter A, Bres SA et al. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor P1-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci USA 2001; 96: 11515-11520.
34. van Houdt IS, Oudejans JJ, van den Eertwegh AJ, Baars A, Vos W, Bladergroen BA et al. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma. Clin Cancer Res 2005; 11: 6400-6407.
35. ten Berge RL, Meijer CJ, Dukers DF, Kummer JA, Bladergroen BA, Vos W et al. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood 2002; 99: 4540-4546.
36. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 2001; 21 5299-5305.
37. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 1996; 92: 3780-3792.
38. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-633.